[go: up one dir, main page]

CN114681152A - Interventional artificial chordae implantation system - Google Patents

Interventional artificial chordae implantation system Download PDF

Info

Publication number
CN114681152A
CN114681152A CN202011640133.7A CN202011640133A CN114681152A CN 114681152 A CN114681152 A CN 114681152A CN 202011640133 A CN202011640133 A CN 202011640133A CN 114681152 A CN114681152 A CN 114681152A
Authority
CN
China
Prior art keywords
anchor
artificial chordae
puncture needle
interventional
far
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011640133.7A
Other languages
Chinese (zh)
Other versions
CN114681152B (en
Inventor
郭荣辉
张庭超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Valgen Medtech Co Ltd
Original Assignee
Hangzhou Valgen Medtech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Valgen Medtech Co Ltd filed Critical Hangzhou Valgen Medtech Co Ltd
Priority to CN202011640133.7A priority Critical patent/CN114681152B/en
Publication of CN114681152A publication Critical patent/CN114681152A/en
Application granted granted Critical
Publication of CN114681152B publication Critical patent/CN114681152B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457Chordae tendineae prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/246Devices for obstructing a leak through a native valve in a closed condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466Delivery devices therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

The invention provides an interventional artificial chordae tendineae implantation system, which comprises an artificial chordae tendineae and an artificial chordae tendineae implantation device. The artificial chordae tendineae implanting device comprises a sheath tube, a clamping assembly, a puncture needle and an anchoring assembly. The clamping assembly comprises a near-end clamping head and a far-end clamping head which are oppositely opened and closed, wherein the near-end clamping head is fixedly connected to the far end of the sheath tube, and a channel which is axially communicated and penetrates through the side wall of the far-end clamping head is arranged on the far-end clamping head; the puncture needle is movably arranged in the sheath tube and the near-end chuck and can penetrate into the far-end chuck through the channel; the anchoring component comprises an anchor and a first pushing component detachably connected with the anchor, and the first pushing component movably penetrates through the puncture needle and pushes the anchor out of the far end of the puncture needle; the artificial chordae tendineae are movably arranged in the first pushing component in a penetrating way, and the far end of the artificial chordae tendineae is connected with the anchor. The interventional artificial chordae tendineae implanting system is simple in structure and easy and convenient to operate, and is beneficial to simplifying the operation process and saving the operation time.

Description

介入式人工腱索植入系统Interventional artificial chordae implantation system

技术领域technical field

本发明涉及医疗器械技术领域,尤其涉及一种介入式人工腱索植入系统。The invention relates to the technical field of medical devices, in particular to an interventional artificial tendon chord implantation system.

背景技术Background technique

二尖瓣为左心房和左心室之间的单向阀门,可以保证血液从左心房流向左心室。如图1所示,正常健康的二尖瓣1可以控制血液从左心房2流到左心室3,同时避免血液从左心室3流到左心房2。二尖瓣1包括一对瓣叶,称为前叶1a及后叶1b。前叶1a及后叶1b分别通过各自的腱索4固定于左心室3的乳头肌上。正常情况下,左心室3收缩时,前叶1a和后叶1b的边缘完全对合,避免血液从左心室3流到左心房2。如图2所示,当二尖瓣1的腱索4部分断裂,将导致二尖瓣1的前叶1a和后叶1b对合不良,由此,当左心室3收缩时,二尖瓣1不能完全关闭,导致血液从左心室3返流至左心房2,从而引起一系列的病理生理改变,称为“二尖瓣返流”。The mitral valve is a one-way valve between the left atrium and the left ventricle that allows blood to flow from the left atrium to the left ventricle. As shown in FIG. 1 , a normal healthy mitral valve 1 can control the flow of blood from the left atrium 2 to the left ventricle 3 while preventing the flow of blood from the left ventricle 3 to the left atrium 2 . The mitral valve 1 includes a pair of leaflets, referred to as an anterior leaflet 1a and a posterior leaflet 1b. The anterior lobe 1a and the posterior lobe 1b are fixed to the papillary muscle of the left ventricle 3 through their chordae tendineae 4, respectively. Under normal circumstances, when the left ventricle 3 contracts, the edges of the anterior lobe 1a and the posterior lobe 1b are completely aligned, preventing blood from flowing from the left ventricle 3 to the left atrium 2. As shown in FIG. 2, when the chordae tendineae 4 of the mitral valve 1 is partially ruptured, the anterior leaflet 1a and the posterior leaflet 1b of the mitral valve 1 will be misaligned. Therefore, when the left ventricle 3 contracts, the mitral valve 1 It cannot be fully closed, causing blood to flow back from the left ventricle 3 to the left atrium 2, causing a series of pathophysiological changes called "mitral regurgitation".

目前可以采用外科手术植入缝线作为人工腱索的方式治疗腱索病变,但是需要采用侵入性开胸技术,并实行全麻、中度低温体外循环作为辅助支持,手术过程复杂、成本高,而且病人受创伤程度高、并发症风险高、恢复过程痛苦。At present, chordae tendineopathy can be treated by surgically implanting sutures as artificial chordae tendineae, but it requires invasive thoracotomy technique, general anesthesia and moderate hypothermic cardiopulmonary bypass as auxiliary support. The operation process is complicated and the cost is high. Moreover, patients suffer from high levels of trauma, high risk of complications, and painful recovery.

另一种治疗方式是通过微创方式植入缝线作为人工腱索。例如,通过经心尖的路径,在左心房侧二尖瓣瓣叶的表面上植入一根缝线,作为人工腱索维持心室壁对瓣叶的拉力。现有的一种经心尖人工腱索植入器械,其远端包括可相对开合的近端夹头与远端夹头以夹持瓣叶,远端夹头内预设有套筒,套筒固定连接缝线,近端夹头内设有穿刺针,如图3所示,穿刺针5穿过瓣叶6后穿入套筒7内部并与套筒7内部的锁止结构相连,通过后撤穿刺针5以带动套筒7及与套筒7相连的缝线8穿过瓣叶6以实现人工腱索植入。然而,这种现有的人工腱索植入系统一方面需要在远端夹头内设置套筒,穿刺针穿刺瓣叶之后连接套筒,才能实现穿刺针与缝线的连接,结构较为复杂;另一方面,需要更换额外的固定系统将缝线固定至心尖、心室壁或乳头肌上,手术过程较复杂,耗时较长。Another treatment option is to implant sutures as artificial chordae tendineae in a minimally invasive way. For example, through a transapical approach, a suture is implanted on the surface of the mitral valve leaflet on the left atrial side as an artificial chordae tendineae to maintain the pull of the ventricular wall on the valve leaflet. An existing transapical artificial chordae implantation device includes a proximal end collet and a distal end collet that can be opened and closed relative to each other to clamp the valve leaflets, the distal end collet is preset with a sleeve, and the sleeve The barrel is fixed with sutures, and a puncture needle is arranged in the proximal end collet. As shown in Figure 3, the puncture needle 5 passes through the valve leaflet 6 and then penetrates into the inside of the sleeve 7 and is connected with the locking structure inside the sleeve 7. The puncture needle 5 is withdrawn to drive the sleeve 7 and the suture 8 connected to the sleeve 7 to pass through the valve leaflet 6 to realize the implantation of the artificial chordae tendineae. However, on the one hand, this existing artificial chordae tendineae implantation system needs to set a sleeve in the distal chuck, and connect the sleeve after the puncture needle punctures the valve leaflet, so that the connection between the puncture needle and the suture can be realized, and the structure is relatively complicated; On the other hand, an additional fixation system needs to be replaced to fix the suture to the apex, ventricular wall, or papillary muscle, which is a complicated and time-consuming procedure.

发明内容SUMMARY OF THE INVENTION

为解决上述技术问题,本发明提供一种介入式人工腱索植入系统,结构简单,操作简便,有利于简化手术过程及节省手术时间。In order to solve the above technical problems, the present invention provides an interventional artificial chordae tendineae implantation system, which has a simple structure and simple operation, which is beneficial to simplify the operation process and save the operation time.

本发明提供的人工腱索植入系统,包括人工腱索及人工腱索植入装置。所述人工腱索植入装置包括鞘管、夹持组件、穿刺针及锚定组件。所述夹持组件包括相对开合的近端夹头和远端夹头,其中,所述近端夹头固定连接于所述鞘管的远端,所述远端夹头上设有沿轴向贯通且穿通所述远端夹头侧壁的通道。所述穿刺针活动穿设于所述鞘管及所述近端夹头内并可经由所述通道穿入所述远端夹头。所述锚定组件包括锚钉及与所述锚钉可拆卸连接的第一推送件,所述第一推送件活动穿设于所述穿刺针内并将所述锚钉推出所述穿刺针的远端。所述人工腱索活动穿设于所述第一推送件内,且其远端连接所述锚钉。The artificial tendon chord implantation system provided by the present invention includes an artificial tendon chord and an artificial tendon chord implantation device. The artificial chordae tendineae implantation device includes a sheath tube, a clamping component, a puncture needle and an anchoring component. The clamping assembly includes a proximal collet and a distal collet that are relatively open and close, wherein the proximal collet is fixedly connected to the distal end of the sheath, and the distal collet is provided with an axial A channel extends through and through the sidewall of the distal collet. The puncture needle is movably passed through the sheath tube and the proximal collet and can penetrate into the distal collet through the channel. The anchor assembly includes an anchor and a first pusher detachably connected to the anchor, the first pusher is movably penetrated into the puncture needle and pushes the anchor out of the puncture needle. remote. The artificial tendon is movably passed through the first pushing member, and the distal end thereof is connected to the anchor.

本发明提供的介入式人工腱索植入系统,在穿刺针内活动穿设锚定组件,在远端夹头上设置沿轴向贯通且穿通远端夹头侧壁的通道供穿刺针活动穿入,通过其中的夹持组件夹持瓣叶,通过穿刺针及其内的锚定组件穿刺瓣叶,随后通过第一推送件将锚钉推出穿刺针及远端夹头直至锚钉锚入心室壁或乳头肌,使得与穿刺针连接的人工腱索借助锚钉锚定于心室壁或乳头肌。与现有技术相比,省略了在远端夹头内设置套筒,穿刺针仅需穿刺瓣叶,无需穿刺针和套筒配合并形成连接的操作,简化了器械结构及操作过程;此外,使用同一套器械即可完成瓣叶穿刺和锚钉固定,操作步骤得以减少,有利于简化手术过程及节省手术时间。In the interventional artificial chordae tendineae implantation system provided by the present invention, an anchoring component is movably passed through the puncture needle, and a channel penetrating axially and penetrating the side wall of the distal end collet is arranged on the distal collet for the puncture needle to move through. The valve leaflet is clamped by the clamping assembly therein, the valve leaflet is punctured by the puncture needle and the anchoring assembly in it, and then the anchor is pushed out of the puncture needle and the distal collet through the first pusher until the anchor is anchored into the ventricle wall or papillary muscle so that the artificial chordae tendineae connected to the needle are anchored to the ventricular wall or papillary muscle by means of anchors. Compared with the prior art, the arrangement of the sleeve in the distal collet is omitted, the puncture needle only needs to puncture the valve leaflet, and the operation of cooperating and forming the connection between the puncture needle and the sleeve is not required, which simplifies the device structure and operation process; in addition, The valve leaflet puncture and anchor fixation can be completed by using the same set of instruments, and the operation steps are reduced, which is beneficial to simplify the operation process and save the operation time.

附图说明Description of drawings

为了更清楚地说明本发明实施例的技术方案,下面将对实施方式中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本发明一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the technical solutions of the embodiments of the present invention more clearly, the following will briefly introduce the accompanying drawings that need to be used in the implementation manner. Obviously, the accompanying drawings in the following description are some embodiments of the present invention. As far as technical personnel are concerned, other drawings can also be obtained based on these drawings without any creative effort.

图1是二尖瓣处于正常状态时的示意图。Figure 1 is a schematic view of the mitral valve in its normal state.

图2是二尖瓣处于关闭不全状态时的示意图。Figure 2 is a schematic view of the mitral valve in a state of insufficiency.

图3是现有技术中的人工腱索植入器械的穿刺过程的示意图。FIG. 3 is a schematic diagram of the puncturing process of the artificial chordae tendineae implantation device in the prior art.

图4是本发明第一实施例提供的介入式人工腱索植入系统的局部立体结构示意图。FIG. 4 is a schematic partial three-dimensional structure diagram of the interventional artificial chordae tendineae implantation system provided by the first embodiment of the present invention.

图5是图4所示的介入式人工腱索植入系统在夹持组件打开时的立体结构示意图。FIG. 5 is a schematic three-dimensional structural diagram of the interventional artificial chord implantation system shown in FIG. 4 when the clamping assembly is opened.

图6是图4所示的介入式人工腱索植入系统的局部轴向剖视图。FIG. 6 is a partial axial cross-sectional view of the interventional artificial chord implantation system shown in FIG. 4 .

图7是图6所示的VII部分的放大示意图。FIG. 7 is an enlarged schematic view of part VII shown in FIG. 6 .

图8是图4所示的远端夹头连接驱动杆的立体结构示意图。FIG. 8 is a schematic three-dimensional structural diagram of the distal collet connecting drive rod shown in FIG. 4 .

图9是图8所示的远端夹头连接驱动杆的端面示意图。FIG. 9 is a schematic view of the end of the distal collet connecting the drive rod shown in FIG. 8 .

图10是图6中人工腱索及锚定组件的立体结构示意图。FIG. 10 is a schematic three-dimensional structural diagram of the artificial chordae tendineae and the anchoring assembly in FIG. 6 .

图11是图10所示的人工腱索及锚定组件的立体分解结构示意图。FIG. 11 is a schematic exploded perspective view of the artificial chordae tendineae and the anchoring assembly shown in FIG. 10 .

图12至图23是介入式人工腱索植入系统的使用过程示意图;12 to 23 are schematic diagrams of the use process of the interventional artificial chord implantation system;

其中,图12示意出了夹持组件夹持瓣叶;Wherein, Figure 12 illustrates the clamping assembly clamping the leaflets;

图13为图12中XIII部位的放大示意图;Fig. 13 is the enlarged schematic diagram of XIII part in Fig. 12;

图14示意出了穿刺针及其内的锚定组件穿刺瓣叶;Figure 14 illustrates the puncture needle and the anchoring assembly within the puncture leaflet;

图15为图14的剖视示意图;Figure 15 is a schematic cross-sectional view of Figure 14;

图16示意出了锚定组件穿出穿刺针及远端夹头;Figure 16 illustrates the anchoring assembly passing through the needle and distal collet;

图17为图16的剖视示意图;Figure 17 is a schematic cross-sectional view of Figure 16;

图18示意出了锚定组件中的第一推送件与锚钉分离;Figure 18 illustrates the separation of the first pusher in the anchor assembly from the anchor;

图19为图18的剖视示意图;Figure 19 is a schematic cross-sectional view of Figure 18;

图20示意出了锚钉锚入乳头肌;Figure 20 illustrates the anchoring of the anchor into the papillary muscle;

图21示意出了除锚钉与人工腱索外,介入式人工腱索植入系统撤出体外;Figure 21 shows that the interventional artificial chord implantation system is withdrawn from the body except for the anchor and the artificial chord;

图22示意出了垫片被推送至瓣叶;Figure 22 illustrates the shim being pushed to the leaflets;

图23示意出了锁结装置将人工腱索锁结固定于垫片远离瓣叶的一侧。Figure 23 illustrates the locking device securing the artificial chordae to the side of the spacer away from the leaflets.

图24是本发明第二实施例提供的介入式人工腱索植入系统的锚定组件及穿刺针的远端部分的轴向剖视图。24 is an axial cross-sectional view of the anchoring assembly and the distal end portion of the puncture needle of the interventional artificial chordae tendineae implantation system provided by the second embodiment of the present invention.

图25是图24中的锚钉连接人工腱索且锚钉的锚片处于合拢状态时的立体结构示意图。FIG. 25 is a schematic three-dimensional structural diagram of the anchor in FIG. 24 when the artificial chordae tendineae are connected and the anchor pieces of the anchor are in a closed state.

图26是图25所示的锚钉连接人工腱索且锚钉的锚片处于展开状态时的立体结构示意图。FIG. 26 is a schematic three-dimensional structural diagram of the anchor shown in FIG. 25 when the artificial chordae is connected and the anchor piece of the anchor is in a deployed state.

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

此外,以下各实施例的说明是参考附加的图示,用以例示本发明可用以实施的特定实施例。本发明中所提到的方向用语,例如,“上”、“下”、“前”、“后”、“左”、“右”、“内”、“外”、“侧面”等,仅是参考附加图示的方向,因此,使用的方向用语是为了更好、更清楚地说明及理解本发明,而不是指示或暗示所指的系统或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。Furthermore, the following descriptions of the various embodiments refer to the accompanying drawings to illustrate specific embodiments in which the invention may be practiced. Directional terms mentioned in the present invention, such as "up", "down", "front", "rear", "left", "right", "inside", "outside", "side", etc., only Reference is made to the directions of the accompanying drawings, therefore, the directional terms used are for better and clearer description and understanding of the present invention, rather than indicating or implying that the system or element referred to must have a particular orientation, be configured in a particular orientation and operation, and therefore should not be construed as limiting the present invention.

需要说明的是,为了更加清楚地描述介入式缝线植入系统及介入式腱索植入系统的结构,本发明在说明书中所述的限定术语“近端”及“远端”为介入医疗领域惯用术语。具体而言,“远端”表示手术操作过程中远离操作人员的一端,“近端”表示手术操作过程中靠近操作人员的一端。将柱体、管体等一类物体的旋转中心轴的方向定义为轴向。周向为围绕柱体、管体等一类物体的轴线的方向(垂直于轴线,同时垂直于截面半径)。径向就是沿直径或半径的直线方向。除非另有定义,本发明所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本发明在说明书中所使用的惯用术语只是为了描述具体实施例的目的,并不能理解为对本发明的限制。It should be noted that, in order to more clearly describe the structure of the interventional suture implantation system and the interventional chord implantation system, the defined terms “proximal end” and “distal end” described in the specification of the present invention refer to interventional medical Domain terminology. Specifically, the "distal end" refers to the end away from the operator during the surgical operation, and the "proximal end" refers to the end close to the operator during the surgical operation. The direction of the central axis of rotation of objects such as cylinders and tubes is defined as the axial direction. The circumferential direction is the direction (perpendicular to the axis and perpendicular to the radius of the section) around the axis of objects such as cylinders and tubes. Radial is the direction of a straight line along a diameter or radius. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The conventional terms used in the specification of the present invention are only for the purpose of describing specific embodiments, and should not be construed as limiting the present invention.

请一并参阅图4至图7,本发明第一实施例提供的介入式人工腱索植入系统9,包括人工腱索10及人工腱索植入装置20,其中,人工腱索植入装置20包括鞘管21、夹持组件23、穿刺针25及锚定组件27。Please refer to FIG. 4 to FIG. 7 together. The interventional artificial chord implantation system 9 provided by the first embodiment of the present invention includes an artificial chord 10 and an artificial chord implantation device 20, wherein the artificial chord implantation device 20 includes a sheath 21 , a clamping assembly 23 , a puncture needle 25 and an anchoring assembly 27 .

具体的,如图4及图5所示,夹持组件23包括可相对开合的近端夹头232和远端夹头234,近端夹头232固定连接于鞘管21的远端;如图6及图7所示,穿刺针25活动穿设于鞘管21及近端夹头232内,远端夹头234上设有沿轴向贯通且穿通远端夹头234侧壁的通道238,以供穿刺针25活动穿入;如图6及图7所示,锚定组件27活动穿设于穿刺针25内,其包括锚钉271、及与锚钉271可拆卸连接的第一推送件273,第一推送件273用于将锚钉271推出穿刺针25的远端;如图6及图7所示,人工腱索10活动穿设于第一推送件273内,且其远端连接锚钉271。Specifically, as shown in FIGS. 4 and 5 , the clamping assembly 23 includes a proximal collet 232 and a distal collet 234 that can be opened and closed relative to each other, and the proximal collet 232 is fixedly connected to the distal end of the sheath tube 21; As shown in FIG. 6 and FIG. 7 , the puncture needle 25 is movably passed through the sheath tube 21 and the proximal end collet 232 , and the distal end collet 234 is provided with a channel 238 which penetrates through the axial direction and penetrates through the side wall of the distal end collet 234 . , for the puncture needle 25 to be movably penetrated; as shown in FIG. 6 and FIG. 7 , the anchoring assembly 27 is movably arranged in the puncture needle 25, which includes an anchor 271 and a first pusher that is detachably connected to the anchor 271 273, the first pusher 273 is used to push the anchor 271 out of the distal end of the puncture needle 25; as shown in FIG. 6 and FIG. Attach anchor 271.

进一步的,如图5及图6所示,夹持组件23还包括至少一根驱动杆236,驱动杆236轴向活动穿设于鞘管21与近端夹头232内,且驱动杆236的远端固定连接远端夹头234,驱动杆236沿轴向移动以带动远端夹头234相对近端夹头232开合,进而夹持瓣叶。需要说明的是,人工腱索植入装置20还包括手柄(图中未示),鞘管21、驱动杆236、穿刺针25以及第一推送件273的近端均延伸至人体外并且与所述手柄连接,所述手柄用于控制鞘管21、驱动杆236、穿刺针25以及第一推送件273等,此处不对手柄的具体结构做赘述。Further, as shown in FIG. 5 and FIG. 6 , the clamping assembly 23 further includes at least one driving rod 236 , the driving rod 236 is axially movably penetrated in the sheath tube 21 and the proximal end collet 232 , and the driving rod 236 is The distal end is fixedly connected to the distal collet 234, and the driving rod 236 moves axially to drive the distal collet 234 to open and close relative to the proximal collet 232, thereby clamping the valve leaflet. It should be noted that the artificial chord implantation device 20 further includes a handle (not shown in the figure), the sheath tube 21, the driving rod 236, the puncture needle 25 and the proximal end of the first pusher 273 all extend outside the human body and are connected with the The handle is used to control the sheath tube 21, the drive rod 236, the puncture needle 25, the first pusher 273, etc., and the specific structure of the handle is not repeated here.

作为植入物的人工腱索10具有柔性,即,人工腱索10在轴向上没有拉伸的情况下,可以任意弯曲;为保证植入安全性,人工腱索10可以由生物相容性良好的高分子材料制成,优选为PTFE、e-PTFE、PET等高分子材料。本实施例中,人工腱索10采用e-PTFE缝线。The artificial chord 10 as an implant has flexibility, that is, the artificial chord 10 can be arbitrarily bent without being stretched in the axial direction; in order to ensure the safety of implantation, the artificial chord 10 can be made of biocompatible It is made of good polymer materials, preferably PTFE, e-PTFE, PET and other polymer materials. In this embodiment, the artificial chordae tendineae 10 use e-PTFE sutures.

请一并参阅图6及图7,近端夹头232及远端夹头234均大致呈圆柱状。近端夹头232及远端夹头234均可以由生物相容性良好的聚合物材料或者金属材料制成,其中,所述聚合物材料包括但不限于PP、PE、PET、PTFE、Pebax、PC中的一种或者几种,所述金属材料包括但不限于不锈钢、镍钛等。近端夹头232与远端夹头234的材料可以相同或者不同。Please refer to FIG. 6 and FIG. 7 together, the proximal collet 232 and the distal collet 234 are both substantially cylindrical. Both the proximal collet 232 and the distal collet 234 can be made of polymer materials or metal materials with good biocompatibility, wherein the polymer materials include but are not limited to PP, PE, PET, PTFE, Pebax, One or more of PCs, the metal materials include but are not limited to stainless steel, nickel titanium, etc. The material of the proximal collet 232 and the distal collet 234 may be the same or different.

如图6及图7所示,近端夹头232可通过螺纹连接、卡合连接、粘接或者焊接等任一方式固定连接于鞘管21的远端。近端夹头232开设有沿轴向贯通其两端的中空内腔,所述中空内腔与鞘管21的内腔连通;此外,近端夹头232还开设有驱动杆腔,所述驱动杆腔位于所述中空内腔的一侧且沿轴向贯通近端夹头232的两端,所述驱动杆腔用于活动穿设驱动杆236,所述驱动杆腔的形状与驱动杆236的形状匹配。As shown in FIG. 6 and FIG. 7 , the proximal collet 232 can be fixedly connected to the distal end of the sheath tube 21 by any method such as screw connection, snap connection, adhesion or welding. The proximal collet 232 is provided with a hollow lumen extending through its two ends in the axial direction, and the hollow lumen is communicated with the lumen of the sheath tube 21; The cavity is located on one side of the hollow inner cavity and penetrates both ends of the proximal collet 232 in the axial direction. The drive rod cavity is used to movably pass through the drive rod 236 . shape to match.

请一并参阅图6至图9,远端夹头234固定连接于驱动杆236的远端,驱动杆236用于带动远端夹头234相对近端夹头232开合以夹持瓣叶。Please refer to FIGS. 6 to 9 together, the distal collet 234 is fixedly connected to the distal end of the driving rod 236 , and the driving rod 236 is used to drive the distal collet 234 to open and close relative to the proximal collet 232 to clamp the valve leaflets.

其中,近端夹头232与远端夹头234夹持瓣叶时,近端夹头232的远端面及远端夹头234的近端面即为两个夹持面。可选的,为更有效地夹持瓣叶,所述两个夹持面中的至少一个设有防滑结构,所述防滑结构可以为凹凸结构、波纹结构等,优选波纹结构。进一步优选的,本实施例中,所述两个夹持面(即近端夹头232的远端面及远端夹头234的近端面)均倾斜于夹持组件23的轴向设置,以方便瓣叶进入并增加夹持面的面积。Wherein, when the proximal collet 232 and the distal collet 234 clamp the valve leaflet, the distal surface of the proximal collet 232 and the proximal surface of the distal collet 234 are two clamping surfaces. Optionally, in order to more effectively clamp the leaflet, at least one of the two clamping surfaces is provided with an anti-skid structure, and the anti-skid structure may be a concave-convex structure, a corrugated structure, etc., preferably a corrugated structure. Further preferably, in this embodiment, the two clamping surfaces (that is, the distal end surface of the proximal end collet 232 and the proximal end surface of the distal end collet 234 ) are inclined to the axial direction of the clamping assembly 23 , To facilitate leaflet entry and increase the area of the clamping surface.

如图6至图9所示,所述通道238包括围绕远端夹头234的轴线且轴向贯通的第一槽体2381以及连通于第一槽体2381并穿通远端夹头234的侧壁的第二槽体2382。具体的,如图9所示,第一槽体2381的垂直于远端夹头234轴向的横截面形状为弧形,所述弧形对应的圆心角大于或者等于180度,且第一槽体2381的直径大于或者等于穿刺针25的直径,以便于穿刺针25穿刺瓣叶后能够无阻碍的进入通道238。本实施例中,第一槽体2381的弧形横截面对应的圆心角等于180度。如图9所示,第二槽体2382的垂直于远端夹头234轴向的横截面形状概为矩形,所述矩形的宽度等于或者小于穿刺针25的直径并大于人工腱索10的直径,以便于人工腱索10穿过瓣叶并且通过锚钉271锚定于心室壁或乳头肌后可自由地从远端夹头234中脱出,使得穿过瓣叶的人工腱索10不受远端夹头234的牵制,从而使远端夹头234可随整个器械顺畅撤出到体外。本实施例中,第二槽体2382的矩形横截面的宽度等于穿刺针25的直径。As shown in FIG. 6 to FIG. 9 , the channel 238 includes a first groove body 2381 surrounding the axis of the distal collet 234 and passing through in the axial direction, and a side wall communicating with the first groove body 2381 and passing through the distal collet 234 The second groove body 2382. Specifically, as shown in FIG. 9 , the cross-sectional shape of the first groove body 2381 perpendicular to the axial direction of the distal end collet 234 is an arc shape, the central angle corresponding to the arc shape is greater than or equal to 180 degrees, and the first groove The diameter of the body 2381 is greater than or equal to the diameter of the puncture needle 25, so that the puncture needle 25 can enter the channel 238 unobstructed after puncturing the valve leaflets. In this embodiment, the central angle corresponding to the arc-shaped cross section of the first groove body 2381 is equal to 180 degrees. As shown in FIG. 9 , the cross-sectional shape of the second groove body 2382 perpendicular to the axial direction of the distal collet 234 is approximately a rectangle, and the width of the rectangle is equal to or smaller than the diameter of the puncture needle 25 and larger than the diameter of the artificial chordae tendineae 10 , so that the artificial chordae tendineae 10 can be freely prolapsed from the distal collet 234 after passing through the valve leaflets and anchored to the ventricular wall or papillary muscle by the anchor 271, so that the artificial chordae tendineae 10 passing through the valve leaflets are not far away The restraint of the end collet 234 enables the distal collet 234 to be smoothly withdrawn from the body along with the entire instrument. In this embodiment, the width of the rectangular cross-section of the second groove body 2382 is equal to the diameter of the puncture needle 25 .

请一并参阅图6及图7,至少一根驱动杆236的远端经鞘管21的内腔及近端夹头232的驱动杆腔穿出近端夹头232的远端,然后与远端夹头234连接,以用于带动远端夹头234相对近端夹头232开合。其中,驱动杆236优选由镍钛管或者镍钛丝制成,且其截面形状可以是圆形、矩形或者三角形等任意形状。可以理解的是,矩形或者三角形截面的驱动杆236在鞘管21的内腔及近端夹头232的驱动杆腔中沿轴向移动时不会发生转动,从而可避免驱动杆236带动远端夹头234相对近端夹头232开合过程中远端夹头234相对近端夹头232旋转。Please refer to FIG. 6 and FIG. 7 together, the distal end of at least one driving rod 236 passes through the inner cavity of the sheath tube 21 and the driving rod cavity of the proximal collet 232 and passes through the distal end of the proximal collet 232, and then passes through the distal end of the proximal collet 232, and then communicates with the distal end of the proximal collet 232. The end collet 234 is connected for driving the distal collet 234 to open and close relative to the proximal end collet 232 . Wherein, the driving rod 236 is preferably made of nickel-titanium tube or nickel-titanium wire, and its cross-sectional shape can be any shape such as a circle, a rectangle or a triangle. It can be understood that the driving rod 236 with a rectangular or triangular cross-section will not rotate when moving axially in the inner cavity of the sheath tube 21 and the driving rod cavity of the proximal collet 232, so as to prevent the driving rod 236 from driving the distal end. During the opening and closing process of the collet 234 relative to the proximal collet 232 , the distal collet 234 rotates relative to the proximal collet 232 .

在其他实施例,近端夹头232与远端夹头234之间可以设置导向杆,所述导向杆与驱动杆236平行,其中,所述导向杆的一端固定连接近端夹头232与远端夹头234中的一个,所述导向杆的另一端滑动连接近端夹头232与远端夹头234中的另一个,由此,驱动杆236带动远端夹头234相对近端夹头232开合时,所述导向杆可以起到导向的作用,且与驱动杆236配合,共同起到止转的作用,同样可以避免远端夹头234相对近端夹头232旋转。In other embodiments, a guide rod may be provided between the proximal collet 232 and the distal collet 234, the guide rod being parallel to the driving rod 236, wherein one end of the guide rod is fixedly connected to the proximal collet 232 and the distal collet 232. One of the end collets 234, the other end of the guide rod is slidably connected to the other one of the proximal end collet 232 and the distal end collet 234, whereby the driving rod 236 drives the distal end collet 234 to be opposite to the proximal end collet When the 232 is opened and closed, the guide rod can play a guiding role, and cooperate with the driving rod 236 to play a role of preventing rotation together, which can also prevent the distal collet 234 from rotating relative to the proximal collet 232 .

请再次参阅图6及图7,穿刺针25为中空的管体,具有一定刚性和柔顺性,优选镍钛材料制成。穿刺针25的内腔用于活动穿设锚定组件27,穿刺针25的远端为尖锐端以便于穿刺由近端夹头232和远端夹头234夹持的瓣叶。Please refer to FIG. 6 and FIG. 7 again, the puncture needle 25 is a hollow tubular body with certain rigidity and flexibility, and is preferably made of nickel-titanium material. The lumen of the puncture needle 25 is used for movably piercing the anchoring assembly 27 , and the distal end of the puncture needle 25 is a sharp end to facilitate puncturing the valve leaflets held by the proximal collet 232 and the distal collet 234 .

穿刺针25穿过瓣叶并穿入远端夹头234的通道238后,锚定组件27可随着穿刺针25一并穿过瓣叶,然后第一推送件273可将锚钉271推出穿刺针25及远端夹头234直至锚钉271锚入心室壁或乳头肌,从而使得连接于锚钉271的人工腱索10锚定于心室壁或乳头肌。After the needle 25 is passed through the leaflet and into the channel 238 of the distal collet 234, the anchor assembly 27 can pass through the leaflet along with the needle 25, and then the first pusher 273 can push the anchor 271 out of the needle The needle 25 and distal collet 234 are used until the anchor 271 is anchored into the ventricular wall or papillary muscle, thereby anchoring the artificial chordae tendineae 10 attached to the anchor 271 to the ventricular wall or papillary muscle.

具体的,请一并参阅图6、图10及图11,本实施例中,锚钉271为螺旋式锚钉,其包括钉座2713及连接于钉座2713的远端的螺旋钉体2715,人工腱索10的远端固定连接于钉座2713,螺旋钉体2715转动以锚入心室壁或乳头肌,从而将人工腱索10锚定于心室壁或乳头肌。钉座2713、螺旋钉体2715选用生物相容性良好的金属材料制成,例如不锈钢。Specifically, please refer to FIG. 6 , FIG. 10 and FIG. 11 together. In this embodiment, the anchor 271 is a helical anchor, which includes a nail base 2713 and a helical nail body 2715 connected to the distal end of the nail base 2713 . The distal end of the artificial chordae 10 is fixedly connected to the nail seat 2713, and the screw body 2715 is rotated to be anchored into the ventricular wall or the papillary muscle, thereby anchoring the artificial chord 10 to the ventricular wall or the papillary muscle. The nail base 2713 and the screw body 2715 are made of metal materials with good biocompatibility, such as stainless steel.

人工腱索10的数量为至少一根,并通过粘接、打结或者压接等任一方式固定连接钉座2713。如图6所示,本实施例中,人工腱索10的数量设置为一根,钉座2713沿轴向设有通孔,人工腱索10的远端穿过钉座2713的通孔并打结固定,使得线结不能通过钉座2713的通孔,从而与钉座2713形成固定连接。需要说明的是,人工腱索10的近端穿出第一推送件273的近端并延伸至人体外,以便于后续进行锁结固定及裁剪。The number of the artificial tendon chords 10 is at least one, and the nail base 2713 is fixedly connected by any method such as gluing, knotting or crimping. As shown in FIG. 6 , in this embodiment, the number of artificial chordae 10 is set to one, the nail base 2713 is provided with a through hole in the axial direction, and the distal end of the artificial chordae 10 passes through the through hole of the nail base 2713 and is drilled. The knot is fixed so that the wire knot cannot pass through the through hole of the nail base 2713 to form a fixed connection with the nail base 2713 . It should be noted that the proximal end of the artificial chordae 10 passes through the proximal end of the first pushing member 273 and extends to the outside of the human body, so as to facilitate subsequent locking and cutting.

如图10及图11所示,第一推送件273为中空的管体,其具有一定刚性和柔顺性,第一推送件273可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek。本实施例中,第一推送件273用于将锚钉271推出穿刺针25的远端,并用于驱动锚钉271旋转以使螺旋钉体2715旋转锚入心室壁或乳头肌。具体的,本实施例中,钉座2713的近端上设有第一连接部2711,第一推送件273的远端对应第一连接部2711设有第二连接部2732,第一连接部2711与第二连接部2732可拆卸连接,使锚钉271与第一推送件273可拆卸连接,进而使第一推送件273沿轴向向远端的移动可将锚钉271推出穿刺针25的远端、及第一推送件273的转动能够带动锚钉271旋转。更具体的,本实施例中,第一连接部2711与第二连接部2732分别设有形状互补、互相拼接的凹凸结构,例如,所述凹凸结构为S形,第一连接部2711与第二连接部2732相互搭接,从而实现锚钉271与第一推送件273的可拆卸连接。需要说明的是,第一连接部2711与第二连接部2732连接时,其内部连通且与第一推送件273的内腔及钉座2713的通孔贯通,以便于人工腱索10穿过。As shown in FIG. 10 and FIG. 11 , the first pushing member 273 is a hollow tube body, which has certain rigidity and flexibility. The first pushing member 273 can be made of a metal material or a polymer material with good biocompatibility. For example Nitinol or Peek. In this embodiment, the first pusher 273 is used to push the anchor 271 out of the distal end of the puncture needle 25 and to drive the anchor 271 to rotate so that the screw body 2715 is rotated and anchored into the ventricular wall or papillary muscle. Specifically, in this embodiment, the proximal end of the nail base 2713 is provided with a first connection portion 2711 , and the distal end of the first pusher 273 is provided with a second connection portion 2732 corresponding to the first connection portion 2711 . The first connection portion 2711 It is detachably connected with the second connecting part 2732, so that the anchor 271 is detachably connected with the first pushing member 273, so that the axial movement of the first pushing member 273 to the distal end can push the anchor 271 out of the distal end of the puncture needle 25. The rotation of the end and the first pushing member 273 can drive the anchor 271 to rotate. More specifically, in this embodiment, the first connecting portion 2711 and the second connecting portion 2732 are respectively provided with concave-convex structures that are complementary in shape and spliced to each other. For example, the concave-convex structure is S-shaped. The connecting parts 2732 overlap each other, thereby realizing the detachable connection between the anchor 271 and the first pushing member 273 . It should be noted that, when the first connecting portion 2711 is connected with the second connecting portion 2732 , the interior thereof communicates with the inner cavity of the first pushing member 273 and the through hole of the nail base 2713 , so as to facilitate the passage of the artificial tendon 10 .

进一步的,如图10及图11所示,本实施例中,锚定组件27还包括限位件275,用于限制第一连接部2711与第二连接部2732的脱离。具体的,限位件275为中空的管体,具有一定刚性和柔顺性,限位件275可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek。其中,第一推送件273与限位件275的材料可以相同或者不相同。本实例例中,第一推送件273与限位件275均为镍钛管。Further, as shown in FIGS. 10 and 11 , in this embodiment, the anchoring assembly 27 further includes a limiting member 275 for limiting the separation of the first connecting portion 2711 and the second connecting portion 2732 . Specifically, the limiting member 275 is a hollow tube body with certain rigidity and flexibility, and the limiting member 275 may be made of a metal material or polymer material with good biocompatibility, such as nickel titanium or Peek. Wherein, the materials of the first pushing member 273 and the limiting member 275 may be the same or different. In this example, the first pushing member 273 and the limiting member 275 are both NiTi tubes.

如图10所示,在一种实施方式中,限位件275轴向活动穿设于第一推送件273内,限位件275沿轴向向远端移动至其远端插入第一连接部2711与第二连接部2732的内部,能够限制第一连接部2711与第二连接部2732的脱离,使得第一推送件273连接于锚钉271,以实现第一推送件273带动锚钉271的移动及转动;限位件275沿轴向向近端移动至其远端从第一连接部2711与第二连接部2732的内部抽离,能够解除其对第一连接部2711与第二连接部2732的限制,使得第一推送件273可与锚钉271分离,以实现锚钉271的释放。As shown in FIG. 10 , in one embodiment, the limiting member 275 is axially movably penetrated in the first pushing member 273 , and the limiting member 275 moves distally in the axial direction until its distal end is inserted into the first connecting portion 2711 and the inside of the second connecting portion 2732 can limit the separation of the first connecting portion 2711 and the second connecting portion 2732, so that the first pushing member 273 is connected to the anchor 271, so that the first pushing member 273 drives the anchor 271. Movement and rotation; the limiting member 275 moves toward the proximal end in the axial direction to its distal end and is pulled away from the interior of the first connecting portion 2711 and the second connecting portion 2732 , which can release its connection to the first connecting portion 2711 and the second connecting portion. 2732, so that the first pusher 273 can be separated from the anchor 271, so as to realize the release of the anchor 271.

在另一种实施方式中,限位件275可以活动套设于第一推送件273外,限位件275沿轴向向远端移动至其远端包绕第一连接部2711与第二连接部2732的外部,能够限制第一连接部2711与第二连接部2732的脱离,使得第一推送件273连接于锚钉271,以实现第一推送件273带动锚钉271的移动及转动;限位件275沿轴向向近端移动至其远端暴露第一连接部2711与第二连接部2732的外部,能够解除其对第一连接部2711与第二连接部2732的限制,使得第一推送件273可与锚钉271分离,以实现锚钉271的释放。可以理解的是,相比于将限位件275穿设于第一推送件273内,将限位件275套设于第一推送件273外会增加穿刺针25的直径,因此,优选限位件275穿设于第一推送件273内。In another embodiment, the limiting member 275 can be movably sleeved outside the first pushing member 273, and the limiting member 275 is moved to the distal end in the axial direction until the distal end of the limiting member 275 surrounds the first connecting portion 2711 and is connected to the second The outside of the first connecting part 2711 and the second connecting part 2732 can limit the separation of the first connecting part 2711 and the second connecting part 2732, so that the first pushing member 273 is connected to the anchor 271, so as to realize the movement and rotation of the anchor 271 driven by the first pushing member 273; The positioning member 275 moves proximally in the axial direction to its distal end to expose the outside of the first connecting portion 2711 and the second connecting portion 2732, which can release the restriction on the first connecting portion 2711 and the second connecting portion 2732, so that the first connecting portion 2711 and the second connecting portion 2732 can be released. The pusher 273 can be separated from the anchor 271 to achieve the release of the anchor 271 . It can be understood that, compared with placing the limiting member 275 inside the first pushing member 273 , setting the limiting member 275 outside the first pushing member 273 will increase the diameter of the puncture needle 25 . The piece 275 is inserted into the first push piece 273 .

本实施例中,介入式人工腱索植入系统9还包括垫片、第二推送件及锁结装置(未图示)。在人工腱索10锚定于心室壁或乳头肌上之后,所述垫片及第二推送件套设于人工腱索10上,且所述第二推送件的远端抵接所述垫片以用于推顶所述垫片沿人工腱索10移动至贴合于瓣叶,所述锁结装置用于将人工腱索10远离锚钉271的一端定位至所述垫片远离瓣叶的一侧上,从而完成人工腱索10的锁结固定。In this embodiment, the interventional artificial chord implantation system 9 further includes a spacer, a second pushing member and a locking device (not shown). After the artificial chord 10 is anchored on the ventricular wall or the papillary muscle, the spacer and the second pusher are sleeved on the artificial chord 10, and the distal end of the second pusher abuts the spacer It is used to push the washer along the artificial chordae 10 to fit the valve leaflet, and the locking device is used to position the end of the artificial chord 10 away from the anchor 271 to the end of the washer away from the valve leaflet. on one side, thereby completing the locking fixation of the artificial chordae 10.

其中,所述第二推送件为中空的管体,具有一定刚性和柔顺性,所述第二推送件可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek;所述垫片为具有一定厚度和尺寸的片状结构,其材质可选择生物相容性良好的聚酯布等材料,所述垫片上设有供人工腱索10活动穿过的通孔,优选的,所述通孔的直径小于穿刺针25的直径,由此,所述垫片贴合于瓣叶后能够覆盖瓣叶上的穿刺口,弥补瓣叶损伤,减小漏血风险,并且可以分散人工腱索10对瓣叶的作用力,有利于降低人工腱索10撕裂瓣叶的风险。Wherein, the second pushing member is a hollow tube body with certain rigidity and flexibility, and the second pushing member can be made of a metal material or polymer material with good biocompatibility, such as nickel titanium or Peek; The gasket is a sheet-like structure with a certain thickness and size, and its material can be selected from materials such as polyester cloth with good biocompatibility. Preferably, the diameter of the through hole is smaller than the diameter of the puncture needle 25, so that the gasket can cover the puncture opening on the valve leaflet after being attached to the valve leaflet, compensate for the damage of the valve leaflet, reduce the risk of blood leakage, and The force acting on the valve leaflets by the artificial chordae tendineae 10 can be dispersed, which is beneficial to reduce the risk of tearing the valve leaflets by the artificial chordae tendineae 10.

此外,还需要说明的是,介入式人工腱索植入系统9还包括导引鞘(未图示),鞘管21轴向活动穿设于所述导引鞘中,且所述导引鞘的远端设有至少一个可调弯段或者预塑形段,可以使所述导引鞘的远端发生弯曲,以使所述导引鞘沿导丝通过人体复杂的管腔结构,鞘管21及其远端的夹持组件23可以通过所述导引鞘的内腔到达预定治疗位点附近。In addition, it should be noted that the interventional artificial chorda tendineae implantation system 9 further includes an introducer sheath (not shown), the sheath tube 21 is axially movably penetrated in the introducer sheath, and the introducer sheath The distal end of the guide sheath is provided with at least one bendable section or pre-shaped section, which can bend the distal end of the introducer sheath, so that the introducer sheath can pass through the complex lumen structure of the human body along the guide wire. 21 and its distal clamping assembly 23 can pass through the lumen of the introducer sheath to the vicinity of the intended treatment site.

请一并参阅图12至图23,以下以经导管二尖瓣腱索修复术为例,说明本发明提供的介入式人工腱索植入系统9的使用过程。其中,手术的介入路径为:经股静脉-下腔静脉-右心房-房间隔-左心房-二尖瓣。Please refer to FIG. 12 to FIG. 23 together. The following uses transcatheter mitral valve chordae tendineae repair as an example to describe the use process of the interventional artificial chordae tendineae implantation system 9 provided by the present invention. Among them, the interventional path of the operation is: through the femoral vein-inferior vena cava-right atrium-atrial septum-left atrium-mitral valve.

第一步:经股静脉穿刺,送入导丝直至右心房,再通过房间隔穿刺针等器械穿刺房间隔的卵圆窝位置,将导丝由右心房送至左心房,到达二尖瓣附近,从而建立从体外到体内的通道。The first step: puncture through the femoral vein, send the guide wire to the right atrium, and then puncture the fossa ovalis of the atrial septum with instruments such as an atrial septal puncture needle, and send the guide wire from the right atrium to the left atrium to reach the vicinity of the mitral valve , thereby establishing a pathway from in vitro to in vivo.

第二步:沿导丝将所述导引鞘输送至二尖瓣附近,撤除导丝保留所示导引鞘,再通过所述导引鞘的内腔,将人工腱索植入装置20的鞘管21的远端部分及夹持组件23输送至二尖瓣附近。Step 2: The guide sheath is transported along the guide wire to the vicinity of the mitral valve, the guide wire is removed to retain the shown guide sheath, and the artificial chordae tendineae are implanted into the inner cavity of the guide sheath The distal portion of the sheath 21 and gripping assembly 23 are delivered to the vicinity of the mitral valve.

第三步:控制驱动杆236向远端移动以带动远端夹头234相对近端夹头232打开,调整鞘管21远端部分的位置和弯曲角度,直至瓣叶6进入近端夹头232与远端夹头234之间的间隙,然后控制驱动杆236向近端移动以带动远端夹头234相对近端夹头232闭合,使瓣叶6被夹持于近端夹头232与远端夹头234之间(如图12及图13所示)。Step 3: Control the drive rod 236 to move distally to drive the distal collet 234 to open relative to the proximal collet 232, and adjust the position and bending angle of the distal end portion of the sheath 21 until the valve leaflet 6 enters the proximal collet 232 The gap with the distal collet 234, and then the drive rod 236 is controlled to move proximally to drive the distal collet 234 to close relative to the proximal collet 232, so that the leaflet 6 is clamped between the proximal collet 232 and the distal collet 232. between the end clamps 234 (as shown in Figures 12 and 13).

第四步:同时推送穿刺针25和锚定组件27,使锚定组件27的远端随穿刺针25一并穿过由近端夹头232与远端夹头234夹持的瓣叶6(如图14及图15所示)。The fourth step: push the puncture needle 25 and the anchor assembly 27 at the same time, so that the distal end of the anchor assembly 27 passes through the valve leaflet 6 ( 14 and 15).

第五步:同步推送锚定组件27中的第一推送件273和限位件275,使锚定组件27伸出穿刺针25及远端夹头234,直至抵达乳头肌或者心室壁附近(如图16及图17所示)。Step 5: Push the first pusher 273 and the limiter 275 in the anchoring assembly 27 synchronously, so that the anchoring assembly 27 extends out of the puncture needle 25 and the distal chuck 234 until it reaches the papillary muscle or the ventricular wall (eg, near the ventricular wall). 16 and 17).

第六步;通过旋转第一推送件273带动锚钉271转动,使螺旋钉体2715锚入乳头肌或者心室壁,进而使人工腱索10锚定于乳头肌或者心室壁上,然后向近端移动限位件275,使得第一推送件273与锚钉271分离,实现锚钉271的释放(如图18及图19所示);此时,近端夹头232及远端夹头234仍夹持瓣叶6,如图20所示。The sixth step; by rotating the first pusher 273, the anchor 271 is driven to rotate, so that the screw body 2715 is anchored into the papillary muscle or the ventricular wall, and then the artificial chordae tendineae 10 is anchored on the papillary muscle or the ventricular wall, and then to the proximal end. Move the limiting member 275 to separate the first pushing member 273 from the anchor 271 to release the anchor 271 (as shown in FIG. 18 and FIG. 19 ); at this time, the proximal collet 232 and the distal collet 234 are still The leaflet 6 is clamped, as shown in FIG. 20 .

第七步:将穿刺针25、第一推送件273及限位件275向近端移动至脱离由近端夹头232与远端夹头234夹持的瓣叶6,然后再次控制驱动杆236向远端移动以带动远端夹头234相对近端夹头232打开,再使得人工腱索10从远端夹头234的通道238中脱出,撤除人工腱索植入装置20;此时,人工腱索10穿过瓣叶6,且远端通过锚钉271固定在乳头肌或者心室壁上,近端延伸至患者体外,如图21所示。Step 7: Move the puncture needle 25, the first pushing member 273 and the limiting member 275 to the proximal end until they are separated from the valve leaflet 6 clamped by the proximal end collet 232 and the distal end collet 234, and then control the driving rod 236 again Move to the distal end to drive the distal collet 234 to open relative to the proximal collet 232, and then make the artificial chord 10 come out from the channel 238 of the distal collet 234, and remove the artificial chord implantation device 20; The chordae tendineae 10 pass through the valve leaflets 6, and the distal ends are fixed to the papillary muscle or the ventricular wall by anchors 271, and the proximal ends extend outside the patient's body, as shown in FIG. 21 .

第八步;如图22所示,将垫片30及第二推送件40分别套设于人工腱索10上,通过第二推送件40将垫片30沿人工腱索10推送至左心房内,直至垫片10接触瓣叶6。The eighth step; as shown in Figure 22, the gasket 30 and the second pusher 40 are respectively sleeved on the artificial chordae 10, and the gasket 30 is pushed into the left atrium along the artificial chordae 10 through the second pusher 40. , until the spacer 10 contacts the leaflet 6 .

第九步:如图23所示,通过锁结装置50将人工腱索10锁结固定于垫片30远离瓣叶6的一侧,并裁断垫片30近侧的多余人工腱索10,完成人工腱索10植入。可以理解的是,在此步骤中,也可以通过打结的方式锁结固定人工腱索10。The ninth step: as shown in FIG. 23, the artificial chordae tendineae 10 are locked and fixed to the side of the gasket 30 away from the leaflet 6 by the locking device 50, and the excess artificial chordae tendineae 10 on the proximal side of the gasket 30 are cut off to complete Artificial chordae tendineae 10 are implanted. It can be understood that, in this step, the artificial chordae tendineae 10 can also be locked and fixed by knotting.

本发明提供的介入式人工腱索植入系统9,在穿刺针25内活动穿设锚定组件27,在远端夹头234上设置沿轴向贯通且穿通远端夹头234侧壁的通道238供穿刺针25活动穿入,通过夹持组件23夹持瓣叶,通过穿刺针25及其内的锚定组件27穿刺瓣叶,随后通过第一推送件273将锚钉271推出穿刺针25及远端夹头234直至锚钉271锚入心室壁或乳头肌,使得与穿刺针25连接的人工腱索10借助锚钉271锚定于心室壁或乳头肌。与现有技术相比,省略了在远端夹头内设置套筒,穿刺针25仅需穿刺瓣叶,无需穿刺针和套筒配合并形成连接的操作,简化了器械结构及操作过程;此外,使用同一套器械即可完成瓣叶穿刺和锚钉固定,操作步骤得以减少,有利于简化手术过程及节省手术时间。In the interventional artificial chordae tendineae implantation system 9 provided by the present invention, the anchor assembly 27 is movably passed through the puncture needle 25 , and the distal collet 234 is provided with a channel penetrating through the axial direction and passing through the side wall of the distal collet 234 238 is for the puncture needle 25 to be movably penetrated, the valve leaflet is clamped by the clamping component 23, the valve leaflet is punctured by the puncture needle 25 and the anchor component 27 in it, and then the anchor 271 is pushed out of the puncture needle 25 by the first pusher 273 and the distal collet 234 until the anchor 271 is anchored into the ventricular wall or the papillary muscle, so that the artificial chordae tendineae 10 connected with the puncture needle 25 is anchored to the ventricular wall or the papillary muscle by means of the anchor 271 . Compared with the prior art, it is omitted to set a sleeve in the distal collet, the puncture needle 25 only needs to puncture the valve leaflet, and the operation of the puncture needle and the sleeve to cooperate and form a connection is not required, which simplifies the structure of the instrument and the operation process; The valve leaflet puncture and anchor fixation can be completed by using the same set of instruments, and the operation steps are reduced, which is beneficial to simplify the operation process and save the operation time.

可以理解的是,本发明的介入式人工腱索植入系统9还可以适用于以下场景,例如,经颈静脉-上腔静脉-右心房-房间隔-左心房-二尖瓣的路径进行经导管介入式二尖瓣的人工腱索植入、经左心房-二尖瓣的路径进行经心房介入式二尖瓣的人工腱索植入,再例如,经股静脉-下腔静脉-右心房-三尖瓣的路径进行经导管介入式三尖瓣的人工腱索植入、经颈静脉-上腔静脉-右心房-三尖瓣的路径进行经导管介入式三尖瓣的人工腱索植入、经右心房-三尖瓣的路径进行经心房介入式三尖瓣的人工腱索植入,此处不做赘述,经导管介入方式比经心房方式对人体的损伤更小。It can be understood that the interventional artificial chordae tendineae implantation system 9 of the present invention can also be applied to the following scenarios. Implantation of prosthetic chordae tendineae of catheter-interventional mitral valve, transatrial interventional mitral valve prosthetic chordae implantation through the route of left atrium-mitral valve, for example, transfemoral vein-inferior vena cava-right atrium - Transcatheter interventional tricuspid valve prosthetic chordae implantation through the tricuspid valve route, transcatheter interventional tricuspid valve prosthetic chordae implantation through the jugular vein-superior vena cava-right atrium-tricuspid valve route The artificial chordae tendineae implantation of the transatrial interventional tricuspid valve is performed through the route of entering and passing through the right atrium-tricuspid valve, which will not be repeated here. The transcatheter intervention method causes less damage to the human body than the transatrial method.

请一并参阅图24至图26,本发明第二实施例提供的介入式人工腱索植入系统与第一实施例提供的介入式人工腱索植入系统9的结构相似,不同之处在于:第二实施例中,锚钉271为自膨式锚钉,第一推送件273的远端抵接锚钉271的近端,第一推送件273可直接将锚钉271抵推出穿刺针25的远端,锚钉271自动膨胀以锚入心室壁或乳头肌。与第一实施例相比,第二实施例中,第一推送件273与锚钉271直接抵接,不需要设置连接部,从而可以省去限位件275,有利于简化介入式人工腱索植入系统的整体结构,节省成本。Please refer to FIG. 24 to FIG. 26 together. The structure of the interventional artificial chord implantation system provided by the second embodiment of the present invention is similar to that of the interventional artificial chord implantation system 9 provided by the first embodiment. The difference is that : In the second embodiment, the anchor 271 is a self-expanding anchor, the distal end of the first pusher 273 abuts against the proximal end of the anchor 271 , and the first pusher 273 can directly push the anchor 271 out of the puncture needle 25 The distal end of the anchor 271 self-expands to anchor into the ventricular wall or papillary muscle. Compared with the first embodiment, in the second embodiment, the first pushing member 273 is in direct contact with the anchor 271, and no connecting portion is required, so that the limiting member 275 can be omitted, which is beneficial to simplify the interventional artificial chordae tendineae The overall structure of the implanted system saves costs.

具体的,如图24至图26所示,第二实施例中,锚钉271包括钉体2717及连接于钉体2717上的至少一个锚片2719。优选的,锚片2719的数量设置为多个,有利于增加锚钉271的锚定力。其中,钉体2717呈环状结构,多个锚片2719沿钉体2717的周向间隔设置于钉体2717的近端,每一锚片2719的近端(即远离钉体2717的一端)为尖锐端。进一步优选的,多个锚片2719沿钉体2717的周向均匀间隔设置,在多个锚片2719锚入心室壁或乳头肌的过程中,心室壁或乳头肌通过多个锚片2719作用于锚钉271的作用力比较均衡,有利于提高锚钉271的锚入稳定性。Specifically, as shown in FIGS. 24 to 26 , in the second embodiment, the anchor 271 includes a nail body 2717 and at least one anchor piece 2719 connected to the nail body 2717 . Preferably, the number of anchor pieces 2719 is set to be multiple, which is beneficial to increase the anchoring force of the anchor pins 271 . The nail body 2717 has a ring-shaped structure, and a plurality of anchor pieces 2719 are arranged at the proximal end of the nail body 2717 at intervals along the circumferential direction of the nail body 2717 . sharp end. Further preferably, a plurality of anchor pieces 2719 are evenly spaced along the circumference of the nail body 2717. During the process of anchoring the plurality of anchor pieces 2719 into the ventricular wall or the papillary muscle, the ventricular wall or the papillary muscle acts on the ventricular wall or the papillary muscle through the plurality of anchor pieces 2719. The acting force of the anchor 271 is relatively balanced, which is beneficial to improve the anchoring stability of the anchor 271 .

需要说明的是,第二实施例中,锚钉271中至少锚片2719是由形状记忆材料经热定型处理制成,优选镍钛合金,锚片2719在自由状态下呈弯曲状,当锚片2719受外力作用时可发生弹性变形而变成平直状。具体的,请一并参阅图24及图25,锚钉271被第一推送件273推出穿刺针25的远端之前,多个锚片2719受穿刺针25的限制处于相对合拢状态;请一并参阅图24及图26,锚钉271被第一推送件273推出穿刺针25的远端之后,多个锚片2719处于展开状态,每一锚片2719的尖锐端朝向钉体2717同时朝外弯曲,以锚入心室壁或乳头肌。It should be noted that, in the second embodiment, at least the anchor piece 2719 in the anchor 271 is made of a shape memory material through heat-setting, preferably a nickel-titanium alloy, and the anchor piece 2719 is curved in a free state. 2719 can be elastically deformed and become straight when subjected to external force. Specifically, please refer to FIG. 24 and FIG. 25 together, before the anchor 271 is pushed out of the distal end of the puncture needle 25 by the first pushing member 273, the anchor pieces 2719 are in a relatively closed state by the restriction of the puncture needle 25; 24 and 26, after the anchor 271 is pushed out of the distal end of the puncture needle 25 by the first pushing member 273, the anchor pieces 2719 are in a deployed state, and the sharp end of each anchor piece 2719 is bent outward toward the nail body 2717 at the same time , to anchor into the ventricular wall or papillary muscle.

在使用第二实施例提供的介入式人工腱索植入系统时,穿刺针25及其内部的锚钉271穿过瓣叶后,穿刺针25继续向远端推进,直至穿刺针25穿入心室壁或乳头肌中,通过向远端推送第一推送件273或者向近端后撤穿刺针25,以使自膨式锚钉271伸出穿刺针25的远端,锚片2719展开从而锚入心室壁或乳头肌中。When the interventional artificial chordae tendineae implantation system provided in the second embodiment is used, after the puncture needle 25 and its inner anchor 271 pass through the valve leaflet, the puncture needle 25 continues to advance distally until the puncture needle 25 penetrates the ventricle In the wall or papillary muscle, by pushing the first pusher 273 distally or withdrawing the puncture needle 25 proximally, so that the self-expanding anchor 271 protrudes from the distal end of the puncture needle 25, the anchor sheet 2719 is expanded to anchor in in the ventricular wall or in the papillary muscles.

可选地,在其他实施例中,钉体2717的远端为尖锐端,锚定组件27还包括活动穿设于穿刺针25内的中间件,锚钉271及第一推送件273活动穿设于所述中间件内。在使用该实施例提供的介入式人工腱索植入系统时,穿刺针25穿刺完瓣叶后即停止推送,然后同步推送所述中间件与第一推送件273直至所述中间件抵接心室壁或乳头肌后,停止推送所述中间件,仅推送第一推送件273,将锚钉271推出所述中间件的远端,锚钉271的钉体2717的尖锐端刺入心室壁或乳头肌,锚片2719展开并锚入心室壁或乳头肌,从而将人工腱索10锚定于心室壁或乳头肌上。Optionally, in other embodiments, the distal end of the nail body 2717 is a sharp end, the anchoring assembly 27 further includes a middle piece movably penetrated in the puncture needle 25, and the anchor 271 and the first pushing member 273 are movably penetrated through in the middleware. When using the interventional artificial chordae tendineae implantation system provided in this embodiment, the puncture needle 25 stops pushing the valve leaflet after puncturing the valve leaflet, and then pushes the middle piece and the first push piece 273 synchronously until the middle piece abuts the ventricle After the wall or papillary muscle, stop pushing the middle piece, only push the first pushing piece 273, push the anchor 271 out of the distal end of the middle piece, and the sharp end of the nail body 2717 of the anchor 271 pierces the ventricular wall or the papilla muscle, the anchor sheet 2719 is deployed and anchored into the ventricular wall or papillary muscle, thereby anchoring the artificial chordae tendineae 10 to the ventricular wall or papillary muscle.

其中,所述中间件为中空的管体,具有一定刚性和柔顺性,所述中间件可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek。Wherein, the middle piece is a hollow tube body with certain rigidity and flexibility, and the middle piece can be made of a metal material or a polymer material with good biocompatibility, such as nickel titanium or Peek.

此外,与第一实施例的不同之处还在于:第二实施例中,环状结构的钉体2717设有容置腔(未标示),所述容置腔固定连接一沿径向延伸的销棒2712,人工腱索10对折,且人工腱索10的对折的部位绕过销棒2712,从而实现人工腱索10与锚钉271的连接。第二实施例中,对折的人工腱索10通过锚钉271锚定于乳头肌或者心肌后,等同于两根人工腱索10的植入。In addition, the difference from the first embodiment is that in the second embodiment, the nail body 2717 of the annular structure is provided with an accommodating cavity (not shown), and the accommodating cavity is fixedly connected with a radially extending For the pin 2712 , the artificial chord 10 is folded in half, and the folded part of the artificial chord 10 bypasses the pin 2712 , so as to realize the connection between the artificial chord 10 and the anchor 271 . In the second embodiment, after the artificial chordae tendineae 10 folded in half is anchored to the papillary muscle or the myocardium through the anchor 271 , it is equivalent to the implantation of two artificial chordae tendineae 10 .

以上是本发明实施例的实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明实施例原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明的保护范围。The above are the implementations of the embodiments of the present invention. It should be pointed out that for those of ordinary skill in the art, without departing from the principles of the embodiments of the present invention, several improvements and modifications can also be made. These improvements and modifications are also It is regarded as the protection scope of the present invention.

Claims (10)

1. An interventional artificial chordae implantation system is characterized by comprising an artificial chordae and an artificial chordae implantation device;
the artificial chordae tendineae implanting device comprises a sheath tube, a clamping assembly, a puncture needle and an anchoring assembly;
the clamping assembly comprises a near-end clamping head and a far-end clamping head which are oppositely opened and closed, wherein the near-end clamping head is fixedly connected to the far end of the sheath tube, and a channel which is axially through and penetrates through the side wall of the far-end clamping head is arranged on the far-end clamping head;
the puncture needle is movably arranged in the sheath tube and the near-end chuck in a penetrating way and can penetrate into the far-end chuck through the channel;
the anchoring component comprises an anchor and a first pushing component detachably connected with the anchor, and the first pushing component is movably arranged in the puncture needle in a penetrating way and pushes the anchor out of the far end of the puncture needle;
the artificial chordae tendineae movably penetrate through the first pushing piece, and the far end of the artificial chordae tendineae is connected with the anchor.
2. The interventional artificial chordae implantation system of claim 1, wherein the anchor has a first connection portion at a proximal end thereof, the first pusher has a second connection portion at a distal end thereof corresponding to the first connection portion, and the first connection portion and the second connection portion have complementary and interlocking protrusions and recesses, respectively.
3. The interventional artificial chordae implantation system of claim 2, wherein the anchor assembly further comprises a stop;
the limiting piece is axially and movably arranged in the first pushing piece in a penetrating manner, and the far end of the limiting piece is inserted into or pulled out of the first connecting part and the second connecting part;
or the limiting part is movably sleeved outside the first pushing part, and the far end of the limiting part is wrapped around or exposed outside the first connecting part and the second connecting part.
4. The interventional artificial chordae implantation system of any one of claims 1-3, wherein the anchor comprises a hub and a helical screw connected to a distal end of the hub, the distal end of at least one of the artificial chordae being fixedly connected to the hub; the first pushing member abuts against the proximal end of the nail seat and drives the anchor to rotate.
5. The interventional artificial chordae implantation system of claim 1, wherein the anchor comprises a nail body and at least one self-expanding anchor blade connected to the nail body, the distal end of the first pusher abutting a proximal end of the nail body.
6. The interventional artificial chordae implantation system of claim 1, wherein the anchor comprises a nail body and at least one self-expanding anchor blade connected to the nail body, and wherein a distal end of the nail body is a sharp end and a distal end of the first pusher abuts a proximal end of the nail body;
the anchoring component further comprises an intermediate piece movably arranged in the puncture needle in a penetrating mode, and the anchor and the first pushing piece are movably arranged in the intermediate piece in a penetrating mode.
7. The interventional artificial chordae implantation system of claim 1, wherein the channel comprises a first slot running axially through and around an axis of the distal collet and a second slot communicating with the first slot and running through a sidewall of the distal collet.
8. The interventional artificial chordae implantation system of claim 7, wherein the first channel has an arc cross-sectional shape with a corresponding central angle greater than or equal to 180 degrees and a diameter greater than or equal to the diameter of the puncture needle; the cross section of the second groove body is rectangular, and the width of the rectangle is equal to or smaller than the diameter of the puncture needle and larger than the diameter of the artificial chordae tendineae.
9. The interventional artificial chordae implantation system of claim 1, further comprising a spacer sleeved over the artificial chordae and a second pusher having a distal end abutting the spacer, the second pusher being configured to push the spacer along the artificial chordae; the gasket is provided with a through hole for the artificial chordae tendineae to movably pass through, and the diameter of the through hole is smaller than that of the puncture needle.
10. The interventional artificial chordae implantation system of claim 9, further comprising a locking device for positioning an end of the artificial chordae distal to the anchor to the spacer.
CN202011640133.7A 2020-12-31 2020-12-31 Interventional artificial chord implantation system Active CN114681152B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011640133.7A CN114681152B (en) 2020-12-31 2020-12-31 Interventional artificial chord implantation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011640133.7A CN114681152B (en) 2020-12-31 2020-12-31 Interventional artificial chord implantation system

Publications (2)

Publication Number Publication Date
CN114681152A true CN114681152A (en) 2022-07-01
CN114681152B CN114681152B (en) 2025-07-15

Family

ID=82135501

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011640133.7A Active CN114681152B (en) 2020-12-31 2020-12-31 Interventional artificial chord implantation system

Country Status (1)

Country Link
CN (1) CN114681152B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040865A1 (en) * 2010-10-01 2012-04-05 Alberto Weber Medical apparatus and method for heart valve repair
CN107569301A (en) * 2017-07-31 2018-01-12 天之纬医疗科技(上海)有限公司 Artificial cords and its artificial cords implant system
US20190183648A1 (en) * 2017-12-20 2019-06-20 W. L. Gore & Associates, Inc. Artificial chordae tendineae repair devices and delivery thereof
CN211934428U (en) * 2019-12-27 2020-11-17 杭州德晋医疗科技有限公司 Transcatheter anchor implantation device and transcatheter anchor implantation system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040865A1 (en) * 2010-10-01 2012-04-05 Alberto Weber Medical apparatus and method for heart valve repair
CN107569301A (en) * 2017-07-31 2018-01-12 天之纬医疗科技(上海)有限公司 Artificial cords and its artificial cords implant system
US20190183648A1 (en) * 2017-12-20 2019-06-20 W. L. Gore & Associates, Inc. Artificial chordae tendineae repair devices and delivery thereof
CN211934428U (en) * 2019-12-27 2020-11-17 杭州德晋医疗科技有限公司 Transcatheter anchor implantation device and transcatheter anchor implantation system

Also Published As

Publication number Publication date
CN114681152B (en) 2025-07-15

Similar Documents

Publication Publication Date Title
US11571307B2 (en) Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US20250032255A1 (en) Percutaneous annuloplasty system with anterior-posterior adjustment
CN110313947B (en) Heart valve repair system
EP3441045B1 (en) Apparatus to draw first and second portions of tissue toward each other
JP4611991B2 (en) Fastening device, device and method for engaging tissue
JP2022534021A (en) Delivery system for heart valve device
RU2019121972A (en) Method and device for transvascular implantation of tendon neochord
US20100268253A1 (en) System and method for closure of an internal opening in tissue, such as a trans-apical access opening
US20190343626A1 (en) Low profile tissue anchor for minimally invasive heart valve repair
CN108289662A (en) Medical devices and methods for heart valve repair
WO2019217638A9 (en) Systems and methods for transcatheter heart valve repair
US20240023951A1 (en) Device for heart repair
WO2019105073A1 (en) Dual-side artificial chordae tendineae implantation system
CN114681132B (en) Heart valve repair device
CN119055407B (en) Cardiac anchors and cardiac anchoring systems
CN114681152A (en) Interventional artificial chordae implantation system
CN215778921U (en) Interventional artificial chordae implantation system
CN212490255U (en) Edge-to-edge repair device and edge-to-edge repair system
US20240325149A1 (en) Method and System for Transcatheter Chordae Tendineae Repair
CN113017921B (en) Transcatheter suture implantation device and transcatheter tendon chord implantation system
CN113274167B (en) Edge-to-edge repair device and edge-to-edge repair system
JP2025507913A (en) Soft Tissue Anchor System for Cardiac Repair
CN120093483A (en) Valve ring retraction device
CN119700373A (en) Atrioventricular valve area reduction system
WO2021129006A1 (en) Transcatheter suture line implantation device and transcatheter chordae tendineae implantation system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant